These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6214246)
21. [DRESS syndrome caused by phenylbutazone]. Valade S; Toledano C; Tiev K; Gain M; Josselin L; Cabane J; Kettaneh A Rev Med Interne; 2009 Aug; 30(8):708-10. PubMed ID: 19100663 [TBL] [Abstract][Full Text] [Related]
22. A review and assessment of drug-induced parotitis. Brooks KG; Thompson DF Ann Pharmacother; 2012 Dec; 46(12):1688-99. PubMed ID: 23249870 [TBL] [Abstract][Full Text] [Related]
23. Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis. Leung AC; McLay A; Dobbie JW; Jones JM Arch Intern Med; 1985 Apr; 145(4):685-7. PubMed ID: 3157355 [TBL] [Abstract][Full Text] [Related]
24. [Parotid duct occlusion with prolamine--sequelae of long-term administration in the animal model]. Schröder M; Chilla R; Arglebe C; Droese M HNO; 1984 Dec; 32(12):507-10. PubMed ID: 6085077 [TBL] [Abstract][Full Text] [Related]
25. A haemorrhagic bullous eruption of the hands caused by phenylbutazone: a report of 3 cases. Millard LG Acta Derm Venereol; 1977; 57(1):83-6. PubMed ID: 74176 [TBL] [Abstract][Full Text] [Related]
26. Salivary gland enlargement and phenylbutazone. Cohen L; Banks P Br Med J; 1966 Jun; 1(5500):1420. PubMed ID: 5932746 [No Abstract] [Full Text] [Related]
27. Salivary gland enlargement and phenylbutazone. Murray-Bruce DJ Br Med J; 1966 Jun; 1(5503):1599-600. PubMed ID: 5940230 [No Abstract] [Full Text] [Related]
28. [On the pathogenesis of the Küttner tumor of the submandibular gland -- Analysis of 349 cases with chronic sialadenitis of the submandibular (author's transl)]. Seifert G; Donath K HNO; 1977 Mar; 25(3):81-92. PubMed ID: 856776 [TBL] [Abstract][Full Text] [Related]
29. [Vasculitis allergica cutis caused by phenylbutazone]. Paschoud JM Dermatologica; 1966; 133(1):76-86. PubMed ID: 4224583 [No Abstract] [Full Text] [Related]
30. Clinicopathological study of myoepithelial sialadenitis and chronic sialadenitis (sialolithiasis). Kondratowicz GM; Smallman LA; Morgan DW J Clin Pathol; 1988 Apr; 41(4):403-9. PubMed ID: 3366925 [TBL] [Abstract][Full Text] [Related]
31. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine). Krook G Contact Dermatitis; 1975 Dec; 1(6):385-6. PubMed ID: 139265 [No Abstract] [Full Text] [Related]
32. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidin). Krook G Contact Dermatitis; 1975 Aug; 1(4):262. PubMed ID: 139243 [No Abstract] [Full Text] [Related]
33. Contact sensitivity to phenylbutazone (Butazolidine) cream. Nayar M; Ng SK Contact Dermatitis; 1991 Oct; 25(4):263-4. PubMed ID: 1839274 [No Abstract] [Full Text] [Related]
34. Allergy from pyrazoline derivatives. Fernández de Corres L; Bernaola G; Lobera T; Leanizbarrutia I; Muñoz D Contact Dermatitis; 1986 Apr; 14(4):249-50. PubMed ID: 2941226 [No Abstract] [Full Text] [Related]
35. Iodide sialadenitis in childhood. Davidson DC; Ford JA; Fox EG Arch Dis Child; 1974 Jan; 49(1):67-8. PubMed ID: 4818097 [No Abstract] [Full Text] [Related]
37. [Differential diagnostic observations on acute sialadenitis]. Knöbber D; Wilhelm HJ; Schätzle W Laryngorhinootologie; 1990 Jun; 69(6):324-6. PubMed ID: 2378660 [TBL] [Abstract][Full Text] [Related]
38. Delayed-type hypersensitivity to mofebutazone underlying a severe drug reaction. Walchner M; Rueff F; Przybilla B Contact Dermatitis; 1997 Jan; 36(1):54-5. PubMed ID: 9034692 [No Abstract] [Full Text] [Related]